Dermatology

Dermatology for NEET PG 2026: Bullous Disorders, Lichen Planus, Leprosy, and High-Yield Signs

By Dr. Utsav Bhattacherjee, MBBS, MBA · 3 Aug 2026 · 20 min read

Last updated: 23 Sept 2026

Dermatology for NEET PG 2026
On this page

Dermatology contributes 3 to 5 percent of the NEET PG paper — approximately 5 to 9 questions out of 180. Unlike some subjects where questions test broad recall, Dermatology questions are frequently morphology-based, pattern-recognition, or classic clinical presentation MCQs. Once you learn the patterns, Dermatology becomes one of the most reliably scorable subjects in the paper.

This guide covers every high-yield Dermatology topic with the depth NEET PG actually demands. Not a textbook overview — a focused breakdown of what appears in PYQs, what the examiners test, and how to answer correctly under exam conditions. For how this subject sits against the rest of the paper, see the complete Dermatology subject wise weightage; for how to fit it into your timetable, see the NEET PG preparation strategy.

Before starting any subject revision, check the NEET PG 2026 score calculator to understand how your current mock test accuracy translates to rank. Getting all Dermatology questions correct versus none is a score swing of 20 to 36 marks — meaningful rank movement at every level.

Dermatology pairs well with the other small, high-repetition subjects. If you are working through them together, Anaesthesia for NEET PG 2026 follows the same approach: a short list of topics that repeat almost verbatim, cycle after cycle.

The 18 Most-Tested Dermatology Topics in NEET PG PYQs

RankTopicFrequencyQuestion Format
1Pemphigus vulgaris vs bullous pemphigoid — comparisonVery HighComparison + IF pattern
2Koebner phenomenon and reverse Koebner — disease listsVery HighDirect factual
3Auspitz sign and other psoriasis signsVery HighDirect factual
4Leprosy — Ridley-Jopling classificationVery HighClassification MCQ
5Leprosy reactions — Type 1 vs Type 2Very HighClinical scenario
6Lichen planus — clinical features, 4Ps, Wickham striaeHighClinical + histology
7Lichen planus pigmentosusHighDirect factual
8Psoriasis — treatment ladder and biologicsHighPharmacology MCQ
9Vitiligo — types and treatmentHighDirect factual
10Scabies — causative organism and treatmentHighPharmacology MCQ
11Dermatophytosis — Wood's lamp findingsModerateDirect factual
12SLE and skin manifestationsModerateClinical scenario
13Acne vulgaris — pathogenesis and treatmentModeratePharmacology MCQ
14Erythema multiforme, SJS, TEN — comparisonModerateSeverity spectrum MCQ
15Drug-induced skin reactionsModeratePharmacology MCQ
16Herpes zoster vs simplexModerateClinical MCQ
17Pemphigus foliaceus — difference from PVLow-ModerateComparison MCQ
18DRESS syndromeLow-ModerateDrug reaction MCQ

Dermatological Signs — The Most Tested in NEET PG

Dermatology signs are consistently tested as direct recall questions. Know every sign, what condition it belongs to, and why it occurs.

Koebner Phenomenon (Isomorphic Response)

The appearance of the same skin lesion at sites of trauma or injury, in a patient who already has that skin disease.

Classic diseases showing Koebner — remember "WPAS": Warts (viral), Psoriasis, Alopecia areata, Syringoma. Also lichen planus, vitiligo, molluscum contagiosum, lichen nitidus, xanthoma and Darier's disease.

PYQ pattern: questions ask which diseases show Koebner. Psoriasis and lichen planus are always correct answers. Pemphigus does not show Koebner.

Pseudo-Koebner Phenomenon

Inoculation of infectious organisms at sites of trauma — the lesion is infectious, not a true isomorphic inflammatory response. Seen with molluscum contagiosum and viral warts, where organisms are physically implanted into traumatised skin.

The distinction: true Koebner means a non-infectious lesion appears at a trauma site; pseudo-Koebner means an infectious lesion is inoculated there.

Reverse Koebner Phenomenon

Clearance of existing skin lesions at sites of trauma or friction. The classic disease is vitiligo — paradoxically, trauma can cause localised repigmentation of vitiligo patches. Also reported in some psoriasis patients.

PYQ pattern: "Reverse Koebner phenomenon is seen in ______" — the answer is vitiligo.

Auspitz Sign

Pinpoint bleeding spots appearing when a psoriatic scale is removed, caused by thinning of the suprapapillary epidermis over dilated dermal capillaries. It is pathognomonic of psoriasis.

Mechanism: suprapapillary plate thinning exposes dermal capillaries, so forcibly removing the scale produces punctate bleeding.

PYQ pattern: "Auspitz sign is seen in ______" — always psoriasis. "Auspitz sign occurs due to ______" — thinning of the suprapapillary plate.

Complete Sign Reference Table

SignDiseaseDescription
Auspitz signPsoriasisPinpoint bleeding on scale removal
Nikolsky sign (positive)Pemphigus vulgarisSkin slides off with lateral pressure
Nikolsky sign (negative)Bullous pemphigoidSkin does not slide off
Bulla spread signPemphigus vulgarisPressure on a bulla causes lateral extension
Koebner phenomenonPsoriasis, LP, vitiligo, wartsLesion appears at trauma site
Reverse KoebnerVitiligoRepigmentation at trauma sites
Pseudo-KoebnerViral warts, molluscumInfectious inoculation at trauma site
Wickham striaeLichen planusWhitish lacy network on papules
Candle grease signPsoriasisScales detach like scraping a candle
Carpet tack signDiscoid lupusFollicular plugging seen on scale removal
Leser-Trélat signInternal malignancySudden eruption of multiple seborrhoeic keratoses
Darier signMastocytosis (urticaria pigmentosa)Urtication on stroking the lesion
Buttonhole signNeurofibromatosisNodules can be pushed through dermis
String of beads signDermatitis herpetiformisGrouped vesicles on elbows
Pathergy test positiveBehçet's diseasePustule forms at needle prick site
Oil drop signPsoriasis (nail)Translucent yellowish patch under nail
Pencil-in-cup deformityPsoriatic arthritisX-ray finding of DIP erosion

Bullous Disorders — The Most Tested Comparison

Pemphigus Vulgaris vs Bullous Pemphigoid

This comparison appears in virtually every NEET PG exam. Every row is exam-relevant.

FeaturePemphigus VulgarisBullous Pemphigoid
Age of onsetMiddle-aged (40–60 years)Elderly (over 60)
Blister levelIntraepidermal (suprabasal)Subepidermal
Nikolsky signPositiveNegative
BullaFlaccid, ruptures easilyTense, thick-roofed, does not rupture easily
Mucosal involvementAlways involved — oral lesions often firstRare
AcantholysisYes — loss of intercellular adhesionNo
Target antigenDesmoglein 3 (oral) and desmoglein 1 (skin)BP180 and BP230 (hemidesmosomes)
AntibodyIgG against desmoglein 3/1IgG against BP180 (collagen XVII) and BP230
Direct IF patternNet-like, fishnet or chicken-wireLinear IgG and C3 at the BMZ
Indirect IFIgG on epithelial cell surfacesIgG along the basement membrane zone
HistologyIntraepidermal blister, acantholytic (Tzanck) cells, tombstone row of basal cellsSubepidermal blister with eosinophilic infiltrate
PrognosisMore severe, higher mortalityBetter
TreatmentHigh-dose systemic steroids plus steroid-sparing agents (azathioprine, rituximab)Topical or systemic steroids; doxycycline with niacinamide

Memory pearls: PV — Positive Nikolsky, Pemphigus, intra-epidermal. BP — Basement membrane, Bullous Pemphigoid, subepidermal, Tense blister. IF pattern: PV is net or chicken-wire (intercellular); BP is linear (at the basement membrane).

Pemphigus Histology

On light microscopy: a suprabasal split forming just above the basal layer; acantholytic cells — rounded keratinocytes that have lost cell-to-cell adhesion; a "tombstone" appearance where basal cells remain attached to the basement membrane in a row; and acantholytic cells on Tzanck smear, which is also positive in herpes infections.

On immunofluorescence: direct IF shows IgG deposits in a net-like, chicken-wire pattern on keratinocyte cell surfaces throughout the epidermis, with C3 deposited alongside. Indirect IF detects patient IgG against epidermal cell surfaces.

Bullous Pemphigoid Histology

On light microscopy: a subepidermal blister forming below the entire epidermis; an eosinophil-rich infiltrate in the blister cavity and dermis; no acantholysis, with the epidermis intact and basal cells in the blister roof.

On immunofluorescence: direct IF shows linear IgG and C3 along the basement membrane zone — the linearity is what distinguishes it from PV's net-like pattern. On salt-split skin, the IgG sits on the epidermal side of the split.

Drug-Induced Bullous Pemphigoid

Drug ClassExamples
DiureticsFurosemide, spironolactone
AntihypertensivesNifedipine, captopril, enalapril
AntibioticsAmoxicillin, ciprofloxacin
AntidiabeticsGliptins (DPP-4 inhibitors) — strong association
AntipsychoticsChlorpromazine
BiologicsTNF-alpha inhibitors

PYQ pattern: the drug class most prominently associated with bullous pemphigoid in recent questions is the DPP-4 inhibitors (gliptins).

Other Bullous Disorders

ConditionKey FeatureTarget Antigen
Pemphigus foliaceusSuperficial blistering, no mucosal involvement; endemic form in Brazil (fogo selvagem)Desmoglein 1 only
Dermatitis herpetiformisIntensely pruritic vesicles on elbows, knees, buttocks; associated with coeliac diseaseEpidermal transglutaminase
Linear IgA diseaseLinear IgA at BMZ; "string of pearls" in childrenIgA against BP180
Epidermolysis bullosa acquisitaMechanobullous, at trauma sites; below lamina densaCollagen VII
Porphyria cutanea tardaSun-exposed areas, fragile skin, milia; urine fluorescenceUroporphyrinogen decarboxylase deficiency

Lichen Planus

Clinical Features — the 4 Ps

Lichen planus is described by the classic four Ps: Pruritic, Purple, Planar (flat-topped) and Polygonal — plus Wickham striae, the whitish lacy lines on the lesion surface.

Sites are the flexor aspects of wrists and forearms, ankles, lower legs and mucosae. Mucosal involvement occurs in 50 to 70 percent of patients, most often as a reticular whitish pattern on the buccal mucosa; the erosive oral form is pre-malignant.

Nail changes include pterygium unguis — adhesion of the proximal nail fold to the nail plate, which is pathognomonic — along with longitudinal ridging and trachyonychia. Koebner phenomenon is positive.

Histology

LayerFinding
EpidermisHyperkeratosis, focal hypergranulosis, irregular acanthosis with saw-tooth rete ridges
Dermoepidermal junctionVacuolar degeneration of basal cells; colloid (Civatte) bodies
DermisBand-like lichenoid lymphocytic infiltrate hugging the DEJ

Saw-tooth rete ridges plus a band-like infiltrate is the classic LP pattern. Colloid bodies — also called Civatte or cytoid bodies — are apoptotic keratinocytes appearing as eosinophilic globular structures at the DEJ.

Variants

VariantSite or Feature
Classic (papular)Flexor wrists and forearms — most common
Oral LPBuccal mucosa, reticular pattern; erosive form pre-malignant
Lichen planus pigmentosusSee below
Hypertrophic LPThick plaques on legs — the most pruritic variant
Bullous LPBlisters within LP lesions
Actinic LPSun-exposed areas; commoner in the Middle East and India
Lichen planopilarisFollicular LP causing scarring alopecia
Inverse LPFlexural areas, groin, axillae
Ulcerative LPChronic painful ulcers on the soles

Lichen Planus Pigmentosus

Lichen planus pigmentosus is a variant characterised by hyperpigmented macular lesions on sun-exposed and flexural sites, without the classic papular morphology. It is far more common in South Asian and Middle Eastern populations than in Western ones, which makes it disproportionately high-yield for Indian exams.

FeatureDetail
Lesion typeDark brown to black macules and patches
DistributionFace (especially forehead and temples), neck, flexural folds
Sun exposureWorse on sun-exposed areas — photodistributed
PruritusMild to moderate; less intense than classic LP
Classic LP featuresUsually absent — no Wickham striae, no flat-topped papules
Mucosal involvementUncommon
CourseChronic; pigmentation may persist long after active disease resolves

Histology shows vacuolar degeneration of the basal layer and melanin incontinence — melanin within dermal macrophages (melanophages) — with a sparse lymphocytic infiltrate at the DEJ, less band-like than classic LP.

Treatment starts with mandatory sun protection, since UV exposure worsens the pigmentation. Topical corticosteroids of moderate potency are used for limited disease, and topical tacrolimus is the steroid-sparing option preferred on the face. Hydroxychloroquine or low-dose systemic steroids are reserved for resistant cases, and Q-switched Nd:YAG laser can address persistent pigmentation once the disease is inactive.

PYQ pattern: questions ask about the distribution (flexural and sun-exposed), the histological finding (melanin incontinence with melanophages), and the treatment.

Leprosy

Ridley-Jopling Classification

Based on the immunological status of the host — the standard classification tested in NEET PG.

TypeBacteriaLepromin TestHistologyClinical Features
Tuberculoid (TT)NoneStrongly positiveWell-formed granulomas surrounded by lymphocytes1–3 hypopigmented, anaesthetic, dry patches with well-defined borders; prominent nerve enlargement
Borderline tuberculoid (BT)FewPositiveLess organised granulomasMore lesions than TT, less clear borders
Mid-borderline (BB)ModerateEquivocalMixed pictureMultiple asymmetric lesions, punched-out appearance
Borderline lepromatous (BL)ManyNegativePoor granulomas, foamy macrophagesMultiple lesions, nerve damage
Lepromatous (LL)Very highStrongly negativeFoamy macrophages (Virchow cells), no granulomas, globi of organismsDiffuse thickening, madarosis, ear lobe thickening, leonine facies; nerve damage late
Indeterminate (I)None to fewVariableNon-specificEarly stage; may progress or regress

The lepromin test measures delayed hypersensitivity to Mycobacterium leprae antigens. It is positive in tuberculoid disease (good cell-mediated immunity) and negative in lepromatous disease (anergic). It is not diagnostic — it indicates immune status.

WHO Classification for Treatment

ClassificationLesionsSkin SmearTreatment
Paucibacillary (PB)1–5 patchesNegativeRifampicin + dapsone for 6 months
Multibacillary (MB)More than 5 patchesPositiveRifampicin + dapsone + clofazimine for 12 months

Anti-Leprosy Drugs

DrugMechanismKey Property
RifampicinRNA polymerase inhibitorBactericidal; most potent single agent; monthly supervised dose
DapsoneDihydropteroate synthase inhibitionBacteriostatic; daily self-administered; causes haemolytic anaemia and methaemoglobinaemia
ClofazimineDNA binding plus anti-inflammatoryBacteriostatic and anti-inflammatory (used in Type 2 reactions); causes orange-red skin discolouration

Leprosy Reactions

FeatureType 1 (Reversal)Type 2 (ENL)
MechanismDelayed hypersensitivity (Type IV) — upregulated CMIImmune complex deposition (Type III)
SpectrumBorderline types (BT, BB, BL)Lepromatous (LL, BL)
Skin lesionsExisting patches become red, oedematous, tenderNew painful red nodules
Nerve involvementAcute nerve function impairment — commonLess prominent
Systemic featuresMinimalFever, malaise, iridocyclitis, orchitis, lymphadenopathy
TreatmentSystemic corticosteroidsThalidomide first-line; systemic steroids

High-yield: thalidomide is the drug of choice for ENL. Steroids treat Type 1.

Psoriasis

Psoriasis presents as an erythematous plaque with silvery-white scale on extensor surfaces — elbows, knees, scalp, lumbar area and nails. The candle grease sign describes scales detaching in layers like scraping a candle; the Auspitz sign is pinpoint bleeding after scale removal; Koebner is positive.

Nail Changes

ChangeDescription
PittingMost common nail change — small punctate depressions
Oil drop signTranslucent yellow-brown spot under the nail
OnycholysisSeparation of nail from nail bed
Subungual hyperkeratosisThickening under the nail
LeukonychiaWhite discolouration

Histology

FindingSignificance
Munro's microabscessesNeutrophil collections in the stratum corneum — pathognomonic
Kogoj's spongiform pustuleNeutrophils between keratinocytes in the upper spinous layer
ParakeratosisRetained nuclei in the stratum corneum
Regular acanthosisElongated rete ridges, test-tube and club shaped
Thin suprapapillary plateExplains the Auspitz sign
Dilated tortuous capillariesIn the dermal papillae

Treatment Ladder

Topical therapy uses corticosteroids first-line for mild disease, with calcipotriol (a vitamin D analogue) — the steroid-calcipotriol combination is standard — plus coal tar, dithranol and tazarotene.

Phototherapy uses narrowband UVB first-line, with PUVA more effective but carrying a higher cancer risk.

Systemic options are methotrexate (most widely used for moderate to severe disease), cyclosporine for rapid control of severe flares, and acitretin for pustular and erythrodermic psoriasis.

BiologicTargetClass
Adalimumab, etanercept, infliximabTNF-alphaAnti-TNF
UstekinumabIL-12 and IL-23Anti-IL-12/23
Secukinumab, ixekizumabIL-17AAnti-IL-17
Guselkumab, risankizumabIL-23 (p19 subunit)Anti-IL-23

PYQ pattern: the drug targeting IL-17 is secukinumab; the drug for pustular psoriasis is acitretin.

Vitiligo

FeatureDetail
PathogenesisAutoimmune destruction of melanocytes
LesionComplete depigmentation — milk-white macules with normal skin texture
Wood's lampEnhanced chalk-white fluorescence
Koebner phenomenonPositive
Reverse KoebnerPositive — trauma can cause repigmentation
DermoscopyPerifollicular pigmentation — a good prognostic sign, indicating a melanocyte reservoir in the follicles
TypeFeatures
Generalised (non-segmental)Most common; bilateral and symmetric; associated with thyroid disease, type 1 diabetes and Addison's
SegmentalUnilateral, follows Blaschko's lines, early onset; responds better to grafting
FocalSingle or few macules in one body segment
AcrofacialDistal digits and periorificial face
UniversalOver 80 percent body involvement — worst prognosis

Treatment uses topical corticosteroids first-line for limited disease, with topical tacrolimus or pimecrolimus preferred on the face and in children. Narrowband UVB is the most effective phototherapy, with PUVA for generalised disease and excimer laser for localised stable patches. Surgical options — split-thickness grafting and melanocyte transplantation — apply only to stable vitiligo. Oral mini-pulse steroids can arrest progression in active disease.

Scabies

FeatureDetail
OrganismSarcoptes scabiei var. hominis
Pathognomonic lesionBurrow — a 5–15 mm curved thread-like channel
Sites in adultsFinger web spaces, wrists, penis
Sites in infantsPalms, soles, face
SymptomIntense pruritus, worse at night
DiagnosisDermoscopy shows the "jet with contrail" sign — mite plus burrow; microscopy of skin scraping
DrugNotes
Permethrin 5% creamFirst-line; head to toe, left 8–12 hours, repeated after a week
Oral ivermectin200 mcg/kg, two doses two weeks apart; first-line for crusted scabies
Benzyl benzoate 25%Traditional, effective, irritating
LindaneAvoid in infants and pregnancy — neurotoxicity
Sulfur ointmentSafest in infants and pregnancy

Norwegian or crusted scabies is a hyperinfestation seen in immunocompromised patients — HIV, the elderly, long-term corticosteroid users — with millions of mites, high contagiousness and crusted hyperkeratotic plaques. Treatment combines ivermectin with a topical scabicide.

Drug-Induced Skin Reactions

ReactionDrugKey Feature
Fixed drug eruptionTetracyclines, NSAIDs, cotrimoxazoleRecurs at the same site on re-exposure
Stevens-Johnson syndromeSulfonamides, carbamazepine, allopurinol, lamotrigineUnder 10 percent BSA, mucosal involvement
Toxic epidermal necrolysisSame drugs, more severeOver 30 percent BSA; Nikolsky positive
DRESS syndromeAnticonvulsants, allopurinol, sulfonamidesEosinophilia with organ involvement; onset 2–8 weeks
PhotosensitivityTetracyclines, amiodarone, chlorpromazine, fluoroquinolonesSun-exposed distribution
Lichenoid drug reactionAntimalarials, gold, captopril, thiazidesMimics lichen planus
Acneiform eruptionSteroids, isoniazid, lithium, OCPMonomorphic comedones
AlopeciaCytotoxics, heparin, anticoagulants, retinoidsDiffuse hair loss

Wood's Lamp Findings

Organism or ConditionColour
Microsporum canis (tinea capitis)Green to yellow-green
Microsporum audouiniiBrilliant green
Trichophyton schoenleinii (favus)Pale greenish-white
Pityriasis versicolor (Malassezia)Yellow-green, coppery-orange
Pseudomonas aeruginosaGreen
Erythrasma (Corynebacterium minutissimum)Coral red
Porphyria cutanea tardaPink-red urine fluorescence
VitiligoChalk-white enhancement

PYQ pattern: erythrasma fluoresces coral red because Corynebacterium produces porphyrins; Microsporum tinea capitis fluoresces green to yellow-green.

High-Yield Dermatology PYQ Checklist

Work through this alongside a timed NEET PG HAMMER test to see which items actually hold up under exam conditions.

  • Nikolsky sign — positive in PV, negative in BP
  • Koebner phenomenon — psoriasis, LP, vitiligo, not pemphigus
  • Reverse Koebner — vitiligo
  • Pseudo-Koebner — viral warts, molluscum
  • Auspitz sign — psoriasis; mechanism is suprapapillary thinning
  • PV target antigen — desmoglein 3 (oral), desmoglein 1 (skin)
  • BP target antigen — BP180 (collagen XVII), BP230
  • PV immunofluorescence — net or chicken-wire, intercellular
  • BP immunofluorescence — linear at the BMZ
  • Colloid (Civatte) bodies — lichen planus
  • Saw-tooth rete ridges with band-like infiltrate — lichen planus
  • Munro's microabscesses — psoriasis, pathognomonic
  • Kogoj's spongiform pustule — psoriasis
  • Lichen planus pigmentosus — melanin incontinence; flexural and sun-exposed
  • Ridley-Jopling TT — lepromin strongly positive, no AFB, well-formed granulomas
  • Ridley-Jopling LL — lepromin negative, very high AFB, Virchow cells
  • WHO paucibacillary — 5 or fewer lesions; rifampicin and dapsone for 6 months
  • WHO multibacillary — more than 5 lesions; add clofazimine, 12 months
  • Type 1 leprosy reaction — borderline types; steroids
  • Type 2 leprosy reaction (ENL) — LL and BL; thalidomide first-line
  • Anti-IL-17 for psoriasis — secukinumab, ixekizumab
  • Anti-IL-23 for psoriasis — guselkumab, risankizumab
  • Permethrin 5% — first-line for scabies
  • Norwegian scabies — immunocompromised; ivermectin
  • Erythrasma on Wood's lamp — coral red
  • Microsporum tinea capitis on Wood's lamp — green to yellow-green
  • Dermoscopy in vitiligo — perifollicular pigmentation indicates good prognosis
  • Pterygium unguis — nail lichen planus, pathognomonic

Practise this on Reflex

Turn what you just read into recall with 14 years of tagged PYQs.

FAQ

Frequently asked questions

The questions aspirants ask most about this topic.

Pemphigus vulgaris versus bullous pemphigoid — comparison, histology and immunofluorescence — plus the Koebner family of phenomena, the Auspitz sign, Ridley-Jopling leprosy classification, leprosy reactions and lichen planus clinical features appear in nearly every cycle. These seven clusters cover roughly 60 to 70 percent of Dermatology marks.

The Nikolsky sign is positive when lateral pressure on apparently normal skin causes it to slide off, indicating poor epidermal adhesion. It is positive in pemphigus vulgaris, where the split is intraepidermal and suprabasal, and negative in bullous pemphigoid, where the blister is subepidermal and tense. It is also positive in staphylococcal scalded skin syndrome and toxic epidermal necrolysis.

It is a variant presenting as dark brown to black macules on sun-exposed areas and flexural folds, particularly common in South Asian patients. Unlike classic LP it has no flat-topped papules and no Wickham striae. Histology shows melanin incontinence with melanophages in the dermis and vacuolar basal degeneration with a sparse infiltrate. Treatment is strict sun protection, topical corticosteroids and topical tacrolimus.

Type 1, the reversal reaction, occurs in borderline types and is a delayed hypersensitivity reaction — existing patches inflame and acute nerve damage may follow. It is treated with systemic corticosteroids. Type 2, erythema nodosum leprosum, occurs in lepromatous disease through immune complex deposition, producing new painful nodules with fever and iridocyclitis. Thalidomide is first-line.

For mild disease, topical corticosteroids combined with calcipotriol. For moderate to severe disease, methotrexate or cyclosporine systemically, or narrowband UVB phototherapy. Biologics targeting TNF-alpha (adalimumab), IL-17 (secukinumab) or IL-23 (guselkumab) are used where conventional systemic therapy fails, and these drug-target pairings are increasingly tested.

Strict photoprotection with broad-spectrum sunscreen is mandatory, since UV exposure worsens the pigmentation. Mid-potency topical corticosteroids reduce inflammation, and topical tacrolimus 0.1% is preferred on the face to avoid steroid side effects. Hydroxychloroquine is used for widespread or resistant disease, and Q-switched Nd:YAG laser helps with persistent pigmentation once the disease is inactive.

About the author

Dr. Utsav Bhattacherjee, MBBS, MBA

CEO, ReflexPrep

LinkedIn

Stay ahead in your preparation

Get expert tips, exam updates, and high-yield insights delivered straight to your inbox.

No spam. Unsubscribe anytime.

More in Subject Notes

View all →